Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

Liezel L. Griffin; Laura Cove-Smith; Hana Alachkar; John A. Radford; Rebecca Brooke; Kim M. Linton

doi:10.1016/j.jdcr.2017.09.028

Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

Liezel L. Griffin, Laura Cove-Smith, Hana Alachkar, John A. Radford, Rebecca Brooke, Kim M. Linton^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	229-231
Number of pages	3
Journal	JAAD Case Reports
Volume	4
Issue number	3
Early online date	23 Feb 2018
DOIs	https://doi.org/10.1016/j.jdcr.2017.09.028
Publication status	Published - 1 Apr 2018

Keywords

adverse events
immune related
lymphoma
nivolumab
programmed death-1 inhibitor
toxic epidermal necrolysis

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jdcr.2017.09.028Licence: CC BY-NC-ND

Cite this

@article{10c0b8d8172c403ca5cf8771f2a6570e,

title = "Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma",

keywords = "adverse events, immune related, lymphoma, nivolumab, programmed death-1 inhibitor, toxic epidermal necrolysis",

author = "Griffin, {Liezel L.} and Laura Cove-Smith and Hana Alachkar and Radford, {John A.} and Rebecca Brooke and Linton, {Kim M.}",

year = "2018",

month = apr,

day = "1",

doi = "10.1016/j.jdcr.2017.09.028",

language = "English",

volume = "4",

pages = "229--231",

journal = "JAAD Case Reports",

issn = "2352-5126",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

AU - Griffin, Liezel L.

AU - Cove-Smith, Laura

AU - Alachkar, Hana

AU - Radford, John A.

AU - Brooke, Rebecca

AU - Linton, Kim M.

PY - 2018/4/1

Y1 - 2018/4/1

KW - adverse events

KW - immune related

KW - lymphoma

KW - nivolumab

KW - programmed death-1 inhibitor

KW - toxic epidermal necrolysis

UR - http://www.scopus.com/inward/record.url?scp=85042386733&partnerID=8YFLogxK

U2 - 10.1016/j.jdcr.2017.09.028

DO - 10.1016/j.jdcr.2017.09.028

M3 - Article

AN - SCOPUS:85042386733

SN - 2352-5126

VL - 4

SP - 229

EP - 231

JO - JAAD Case Reports

JF - JAAD Case Reports

IS - 3

ER -

Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma

Keywords

Research Beacons, Institutes and Platforms

UN SDGs

Access to Document

Other files and links

Cite this